Zenith Drugs Ltd. - Research Center
Group () BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | |
|---|---|
| Sales | 69.41 |
| Operating profit | 11.09 |
| Interest | 1.46 |
| Gross profit | 9.71 |
| EPS (Rs) | 142.53 |
Half yearly
results in details
| Sep ' 23 | |
|---|---|
| Other income | 0.08 |
| Stock adjustment | 1.40 |
| Raw material | 40.22 |
| Power and fuel | - |
| Employee expenses | 3.29 |
| Excise | - |
| Admin and selling expenses | - |
| Research and development expenses | - |
| Expenses capitalised | - |
| Other expenses | 13.41 |
| Provisions made | - |
| Depreciation | 0.63 |
| Taxation | 1.93 |
| Net profit / loss | 5.70 |
| Extra ordinary item | -1.44 |
| Prior year adjustments | - |
| Equity capital | 0.40 |
| Equity dividend rate | - |
| Agg.of non-prom. shares (Lacs) | - |
| Agg.of non promotoholding (%) | - |
| OPM (%) | 15.98 |
| GPM (%) | 13.97 |
| NPM (%) | 8.20 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis